Here is executive compensation for the CEOs of publicly traded, U.S.-based gastroenterology companies.
GI & Endoscopy
A study, presented at the American Society of Clinical Oncology Annual Meeting, examined if researchers could reduce chemotherapy from six months to three months when treating stage III colorectal cancer patients.
John Weippert, DO, is a gastroenterologist at Warren, Ohio-based NEO Gastroenterology and Endoscopy Center.
The FDA awarded Becton, Dickinson and Company's BD Max's extended enteric bacterial panel 510(k) clearance.
Washington, D.C.-based Capital Digestive Care opened a new clinic in Glenn Dale, Md.
Boston Scientific is investing $19 million in a new Galway, Ireland-based RoadRunner endoscopy design facility, Galway Advertiser reports.
John Haydek, MD, is a gastroenterologist at Knoxville, Tenn.-based Gastrointestinal Associates.
Takeda Pharmaceuticals is relocating approximately 100 researchers to Boston during fiscal year 2017, Nikkei Asian Review reports.
A study published in Microbiome examined bidirectional brain-gut microbiome interactions, gut microbial composition and if there are correlations between gut microbial measures and structural brain signatures in irritable bowel syndrome patients.
The American Gastroenterological Association released a new care pathway for managing U.S.-based patients with hepatitis C viral infections.
